PT1532105E - Derivados de antracilo possuindo uma actividade anticolecistoquinina (anti-cck-1), um processo para a sua preparação e sua utilização farmacêutica - Google Patents
Derivados de antracilo possuindo uma actividade anticolecistoquinina (anti-cck-1), um processo para a sua preparação e sua utilização farmacêutica Download PDFInfo
- Publication number
- PT1532105E PT1532105E PT03766505T PT03766505T PT1532105E PT 1532105 E PT1532105 E PT 1532105E PT 03766505 T PT03766505 T PT 03766505T PT 03766505 T PT03766505 T PT 03766505T PT 1532105 E PT1532105 E PT 1532105E
- Authority
- PT
- Portugal
- Prior art keywords
- sub
- chosen
- group
- cck
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002TO000674A ITTO20020674A1 (it) | 2002-07-26 | 2002-07-26 | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1532105E true PT1532105E (pt) | 2009-06-29 |
Family
ID=11459544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03766505T PT1532105E (pt) | 2002-07-26 | 2003-07-23 | Derivados de antracilo possuindo uma actividade anticolecistoquinina (anti-cck-1), um processo para a sua preparação e sua utilização farmacêutica |
Country Status (11)
Country | Link |
---|---|
US (1) | US7294648B2 (pt) |
EP (1) | EP1532105B1 (pt) |
JP (1) | JP4530853B2 (pt) |
AT (1) | ATE433439T1 (pt) |
AU (1) | AU2003253114B8 (pt) |
CA (1) | CA2493789C (pt) |
DE (1) | DE60327932D1 (pt) |
ES (1) | ES2325496T3 (pt) |
IT (1) | ITTO20020674A1 (pt) |
PT (1) | PT1532105E (pt) |
WO (1) | WO2004013087A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ542491A (en) | 2003-03-28 | 2009-04-30 | Janssen Pharmaceutica Nv | Benzo[1,2,5]thiadiazole compounds as CCK2 modulators |
PT1651621E (pt) * | 2003-08-08 | 2008-09-30 | Janssen Pharmaceutica Nv | Compostos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de cck2 |
BRPI0516027A (pt) | 2004-09-24 | 2008-08-19 | Janssen Pharmaceutica Nv | compostos de sulfonamida |
-
2002
- 2002-07-26 IT IT2002TO000674A patent/ITTO20020674A1/it unknown
-
2003
- 2003-07-23 CA CA2493789A patent/CA2493789C/en not_active Expired - Fee Related
- 2003-07-23 AT AT03766505T patent/ATE433439T1/de not_active IP Right Cessation
- 2003-07-23 EP EP03766505A patent/EP1532105B1/en not_active Expired - Lifetime
- 2003-07-23 DE DE60327932T patent/DE60327932D1/de not_active Expired - Lifetime
- 2003-07-23 ES ES03766505T patent/ES2325496T3/es not_active Expired - Lifetime
- 2003-07-23 WO PCT/IB2003/002922 patent/WO2004013087A1/en active Application Filing
- 2003-07-23 JP JP2004525597A patent/JP4530853B2/ja not_active Expired - Fee Related
- 2003-07-23 US US10/523,075 patent/US7294648B2/en not_active Expired - Fee Related
- 2003-07-23 PT PT03766505T patent/PT1532105E/pt unknown
- 2003-07-23 AU AU2003253114A patent/AU2003253114B8/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ATE433439T1 (de) | 2009-06-15 |
ES2325496T3 (es) | 2009-09-07 |
DE60327932D1 (de) | 2009-07-23 |
WO2004013087A1 (en) | 2004-02-12 |
EP1532105B1 (en) | 2009-06-10 |
AU2003253114B2 (en) | 2009-07-16 |
US7294648B2 (en) | 2007-11-13 |
CA2493789C (en) | 2012-05-01 |
JP2005533866A (ja) | 2005-11-10 |
ITTO20020674A0 (it) | 2002-07-26 |
JP4530853B2 (ja) | 2010-08-25 |
AU2003253114A1 (en) | 2004-02-23 |
EP1532105A1 (en) | 2005-05-25 |
AU2003253114B8 (en) | 2009-08-13 |
US20060111304A1 (en) | 2006-05-25 |
ITTO20020674A1 (it) | 2004-01-26 |
CA2493789A1 (en) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0413232B8 (pt) | composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto | |
MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
IL160304A0 (en) | ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR delta | |
MXPA04001240A (es) | Analogos antitumorales. | |
ES2093332T3 (es) | Nuevos derivados arilglicinamidicos, su procedimiento de preparacion y su uso para el tratamiento de la disuria. | |
DK1204662T3 (da) | Azaindoler med serotoninreceptoraffinitet | |
PT1468692E (pt) | Utilizacao de 2,6-dialquil-4-sililfenois para o tratamento do xantoma | |
DE68926981D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung | |
BRPI0210746B8 (pt) | derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação | |
PT1532105E (pt) | Derivados de antracilo possuindo uma actividade anticolecistoquinina (anti-cck-1), um processo para a sua preparação e sua utilização farmacêutica | |
TW200505446A (en) | Inhibitor of cox | |
CA2014521A1 (en) | 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them | |
MX9206930A (es) | Nuevos compuestos | |
AU703092B2 (en) | Benzene derivatives | |
CA2027542A1 (en) | Uv-absorbing cyclic enaminoketones | |
DE69702955T2 (de) | Bis-Imide Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitung | |
DE60026161D1 (de) | Amidin-derivate, ihre herstellung und verwendung als medikamenten | |
DE60238847D1 (de) | Pyrimidinderivate enthaltendes medikament | |
EP1241166A4 (en) | 3-MEHTYL CHROMAN AND THIOCHROME DERIVATIVES | |
MY111111A (en) | Novel (1-phenyl-1-heterocyclyl) methanol and (1-phenyl -1-heterocyclyl) methylamine drrivatives | |
TH37483B (th) | อนุพันธ์ 5-เมโรคิลแนพธาลีน | |
WO2004026548A3 (fr) | Procede de traitement chimique d'un substrat en un materiau comprenant du bois | |
TH32102A (th) | สารประกอบแนพธิล สารอินเทอมิเดียท สารผสม และวิธีใช้ | |
HUP0303691A2 (hu) | Uretánszármazékok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására | |
TH14992EX (th) | อนุพันธ์แอลกอฮอล์หรือแอลดิไฮด์ และการใช้สารเหล่านั้น |